Organic AIE Nanoradiosensitizer Potentiates X‐Ray Triggered Continuous Reactive Oxygen Species Generation for Potent Cancer Radioimmunotherapy
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
Organic radiosensitizers (ORSs), with structural versatility, hold promise for sensitizing radiotherapy (RT) by interacting with X‐ray photons to generate reactive oxygen species (ROS). They often consist of low‐Z elements that have inherently low X‐ray deposition capability. However, current ORSs suffer from short circulation half‐lives and low tumor retention, contradicting their requirements for sustained ROS generation upon RT in tumor sites. Herein, a glutathione‐responsive system is prepared, loaded with aggregation‐induced emission molecules (TPEPy‐I) and Ferriprotoporphyrin IX chloride (Hemin), to act as an ORS (named THN) for X‐ray triggered sustained ROS generation for efficient antitumor immunotherapy. In detail, THN effectively deposited X‐ray photons, which interact with water molecules to generate abundant ROS under external radiation. Subsequently, THN‐mediated radiosensitization stimulated tumor cells to produce hydrogen peroxide (H 2 O 2 ) by upregulating NOX4 protein, promoting the chemodynamic process of Hemin reacting with H 2 O 2 to continuously produce hydroxyl radicals. The double‐promoting ROS generation of THN induced massive immunogenic cancer cell death and polarized M2 macrophages into the M1 phenotype for enhanced antitumor immunotherapy. Experiments revealed that THN‐sensitized RT inhibited tumor recurrence and increased memory T‐cell proportion for long‐term antitumor immunity. The developed ORS has great clinical potential as both a radiosensitizer and a post‐RT immunomodulatory agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These platforms typically incorporate catalytic components, including manganese-, iron-, or copper-containing materials, that exploit endogenous hydrogen peroxide within the tumor microenvironment to generate highly reactive hydroxyl radicals through Fenton or Fenton-like reactions [87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with these vulnerabilities, many of the more advanced nanoplatforms identified in this review—including systems targeting sustained ROS amplification, redox disruption, ferroptosis-associated pathways, and immune activation—were preferentially evaluated in TNBC models [23,26,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In catalytic and chemodynamic systems, sustained intracellular ROS production can maintain oxidative stress beyond the initial irradiation event, promoting persistent DNA damage, delaying repair processes, and increasing the probability of irreversible reproductive cell death [17,31,68,77,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These observations support the emerging view that durable disruption of tumor redox homeostasis may be more therapeutically relevant than transient ROS amplification alone, particularly in tumors with high antioxidant capacity and adaptive stress-response pathways [31,68,77,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition to physical dose amplification, several contemporary nanoplatforms incorporate catalytic or chemodynamic mechanisms capable of sustaining oxidative stress through endogenous hydrogen peroxide conversion and glutathione depletion [31,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [90]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Geant4 developments and applications
Allison, J., Amako, K., Apostolakis, J., Araujo, H., Arce Dubois, P., Asai, M., Barrand, G., Capra, R., Chauvie, S., Chytracek, R., et al. (2006) · IEEE Transactions on Nuclear Science · doi:10.1109/tns.2006.869826 · Cited by 6,946
Targeting Ferroptosis as a Vulnerability in Cancer
Lei, G., Zhuang, L., & Gan, B. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00459-0 · Cited by 2,252
NIR‐II AIEgens: A Win–Win Integration towards Bioapplications
Xu, W., Wang, D., & Tang, B. Z. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202005899 · Cited by 457
Self-citationSong, G., Liang, C., Gong, H., Li, M., Zheng, X., Cheng, L., Yang, K., Jiang, X., & Liu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503006 · Cited by 353
Experimental benchmarks of the Monte Carlo code penelope
Sempau, J., Fernández-Varea, J. M., Acosta, E., & Salvat, F. (2003) · Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms · doi:10.1016/s0168-583x(03)00453-1 · Cited by 347
Ning, S., Lyu, M., Zhu, D., Lam, J. W. Y., Huang, Q., Zhang, T., & Tang, B. Z. (2023) · ACS Nano · doi:10.1021/acsnano.3c00326 · Cited by 293
Self-citationRecent applications of immunomodulatory biomaterials for disease immunotherapy
Dai, H., Fan, Q., & Wang, C. (2022) · Exploration · doi:10.1002/exp.20210157 · Cited by 268
Wang, K., Li, Y., Wang, X., Zhang, Z., Cao, L., Fan, X., Wan, B., Liu, F., Zhang, X., He, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38601-7 · Cited by 253
Self-citationZhu, D., Chen, H., Huang, C., Li, G., Wang, X., Jiang, W., & Fan, K. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202110268 · Cited by 205
Bian, H., Ma, D., Zhang, X., Xin, K., Yang, Y., Peng, X., & Xiao, Y. (2021) · Small · doi:10.1002/smll.202100398 · Cited by 201
Self-citationOrganic phosphorescent nanoscintillator for low-dose X-ray-induced photodynamic therapy
Wang, X., Sun, W., Shi, H., Ma, H., Niu, G., Li, Y., Zhi, J., Yao, X., Song, Z., Chen, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32054-0 · Cited by 189
Self-citationCore–shell Au@MnO2 nanoparticles for enhanced radiotherapy via improving the tumor oxygenation
Yi, X., Chen, L., Zhong, X., Gao, R., Qian, Y., Wu, F., Song, G., Chai, Z., Liu, Z., & Yang, K. (2016) · Nano Research · doi:10.1007/s12274-016-1205-8 · Cited by 180
Peng, H., Yao, F., Zhao, J., Zhang, W., Chen, L., Wang, X., Yang, P., Tang, J., & Chi, Y. (2023) · Exploration · doi:10.1002/exp.20220115 · Cited by 169
Lang, T., Liu, Y., Zheng, Z., Ran, W., Zhai, Y., Yin, Q., Zhang, P., & Li, Y. (2019) · Advanced Materials · doi:10.1002/adma.201806202 · Cited by 165
Biomimetic copper single-atom nanozyme system for self-enhanced nanocatalytic tumor therapy
Zhu, D., Ling, R., Chen, H., Lyu, M., Qian, H., Wu, K., Li, G., & Wang, X. (2022) · Nano Research · doi:10.1007/s12274-022-4359-6 · Cited by 135
Zheng, Y., Sun, L., Guo, J., & Ma, J. (2023) · 癌症:英文版 · doi:10.1002/cac2.12487 · Cited by 125
A cascade X-ray energy converting approach toward radio-afterglow cancer theranostics
Xu, C., Qin, X., Wei, X., Yu, J., Zhang, Y., Zhang, Y., Ding, D., Song, J., & Pu, K. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01809-9 · Cited by 114
Zhu, D., Zhang, J., Luo, G., Duo, Y., & Tang, B. Z. (2021) · Advanced Science · doi:10.1002/advs.202004769 · Cited by 109
Self-citationPROTAC Prodrug‐Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer
Zhang, S., Lai, Y., Pan, J., Saeed, M., Li, S., Zhou, H., Jiang, X., Gao, J. X., Zhu, Y., Yu, H., et al. (2024) · Advanced Materials · doi:10.1002/adma.202314132 · Cited by 100
Lyu, M., Zhu, D., Duo, Y., Li, Y., & Quan, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119656 · Cited by 98
Metal-Phenolic Nanomedicines Regulate T-Cell Antitumor Function for Sono-Metabolic Cancer Therapy
Yan, J., Li, W., Tian, H., Li, B., Yu, X., Wang, G., Sang, W., & Dai, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c02428 · Cited by 96
Wang, Y., Wang, Z., Jia, F., Xu, Q., Shu, Z., Deng, J., Li, A., Yu, M., & Yu, Z. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.003 · Cited by 85
Self-citationZhang, N., Ping, W., Rao, K., Zhang, Z., Huang, R., Zhu, D., Li, G., & Ning, S. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.045 · Cited by 80
Self-citationTailoring the Amphiphilic Structure of Zwitterionic AIE Photosensitizers to Boost Antitumor Immunity
Zhang, T., Yang, X. W., Ou, X., Lee, M. M. S., Zhang, J., Xu, C., Yu, X., Gong, P., Lam, J. W. Y., Zhang, P., et al. (2023) · Advanced Materials · doi:10.1002/adma.202303186 · Cited by 79
Self-citationWang, Z., Ma, W., Yáng, Z., Kiesewetter, D. O., Wu, Y., Lang, L., Zhang, G., Nakuchima, S., Chen, J., Su, Y. P., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c09831 · Cited by 78
Qiao, W., Ma, T., Xie, G., Xu, J., Yang, Z., Zhong, C. M., Jiang, H., Xia, J., Zhang, L., Zhu, J., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c07764 · Cited by 77
Enhancing Ferroptosis-Mediated Radiosensitization via Synergistic Disulfidptosis Induction
Li, Q., Wu, Z., Chen, S., Liang, Y., Zhu, K., Su, N., Liu, T., & Zhao, B. (2024) · ACS Nano · doi:10.1021/acsnano.4c15932 · Cited by 73
Self-citationRational design of ICD-inducing nanoparticles for cancer immunotherapy
Zhang, Z., Pan, Z., Li, Q., Huang, Q., Shi, L., & Liu, Y. (2024) · Science Advances · doi:10.1126/sciadv.adk0716 · Cited by 72
Self-citationZeng, F., Fan, Z., Li, S., Li, L., Sun, T. S., Qiu, Y., Nie, L., & Huang, G. (2023) · ACS Nano · doi:10.1021/acsnano.3c03378 · Cited by 63
A biomimetic nanozyme/camptothecin hybrid system for synergistically enhanced radiotherapy
Zhu, D., Lyu, M., Jiang, W., Suo, M., Huang, Q., & Li, K. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00676a · Cited by 63
Self-citationItaconate protects ferroptotic neurons by alkylating GPx4 post stroke
Wei, C., Xiao, Z., Zhang, Y., Luo, Z., Liu, D., Hu, L., Shen, D., Liu, M., Shi, L., Wang, X., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01303-8 · Cited by 61
Self-citationLiu, N., Lin, Q., Huang, Z., Liu, C., Qin, J., Yu, Y., Chen, W., Zhang, J., Jiang, M., Gao, X., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c10133 · Cited by 56
Self-citationBiomimetic Single‐Atom Nanozyme for Dual Starvation‐Enhanced Breast Cancer Immunotherapy
Zhang, N., Ping, W., Xiang, J., Chu, S., Li, D., Ning, S., Zhu, D., Zeng, W., & Xu, Q. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401362 · Cited by 55
Self-citationChen, H., Luo, X. Q., Huang, Q., Liu, Z., Lyu, M., Chen, D., Mo, J., & Zhu, D. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.146276 · Cited by 55
Self-citationKuninty, P. R., Binnemars‐Postma, K., Jarray, A., Pednekar, K. P., Heinrich, M. A., Pijffers, H. J., ten Hoopen, H., Storm, G., van Hoogevest, P., den Otter, W. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32091-9 · Cited by 54
Pan, Y., Suo, M., Huang, Q., Lyu, M., Jiang, Y., Wang, S., Tang, W., Ning, S., & Zhang, T. (2024) · Aggregate · doi:10.1002/agt2.432 · Cited by 52
Self-citationFe/Al‐LDH Nanomedicine for Antitumor Ferroptosis‐Immunotherapy by Immunosuppression Reversal
Fang, W., Yu, Z., Hu, P., & Shi, J. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202405483 · Cited by 52
Ning, S., Zhang, X., Suo, M., Lyu, M., You, P., Jiang, Y. H., Yang, H., Lam, J. W. Y., Zhang, T., Pan, L., et al. (2023) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2023.101505 · Cited by 49
Self-citationHasan, A. N., Selvakumar, A., Shabrova, E. V., Xr, L., Afridi, F., Heller, G., Rivière, I., Sadelain, M., Dupont, B., & O'Reilly, R. J. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12816 · Cited by 46
X‐ray‐Guided In Situ Genetic Engineering of Macrophages for Sustained Cancer Immunotherapy
Zhao, C., Cheng, Y., Huang, P., Wang, C., Wang, W., Wang, M., Shan, W., & Deng, H. (2023) · Advanced Materials · doi:10.1002/adma.202208059 · Cited by 45
Ma, X., Lin, N., Yang, Q., Liu, P., Ding, H., Xu, M., Ren, F., Shen, Z., Hu, K., Meng, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52278-6 · Cited by 44
Bakshi, J., & Mishra, K. P. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104912 · Cited by 42
Zhang, X., Zhang, Y., Lv, X., Zhang, P., Xiao, C., & Chen, X. (2024) · ACS Nano · doi:10.1021/acsnano.4c11275 · Cited by 41
Self-citationDNA Nanoclusters Combined with One‐Shot Radiotherapy Augment Cancer Immunotherapy Efficiency
Xie, Y., Li, H., Xu, L., Zou, H., Wang, X., He, X., Tang, Q., Zhou, Y., Zhao, X., Chen, X., et al. (2023) · Advanced Materials · doi:10.1002/adma.202208546 · Cited by 40
Xiong, W., Wang, L., Chen, X., Tang, H., Cao, D., Zhang, G., & Chen, W. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00888e · Cited by 39
Self-citationZheng, J., Ge, H., Zhou, D., Yao, Q., Long, S., Sun, W. C., Fan, J., Du, J., & Peng, X. (2023) · Advanced Materials · doi:10.1002/adma.202308205 · Cited by 37
The wonders of X-PDT: an advance route to cancer theranostics
Mushtaq, A., Iqbal, M. Z., Tang, J., & Sun, W. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02931-5 · Cited by 37
Wang, Y., Fan, Y., Zhang, X., Liu, J., Sun, D., Liu, X., Bai, G., Liu, X., Wang, H., Zhang, Y., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123037 · Cited by 37
Self-citationNing, S., Suo, M., Huang, Q., Gao, S., Qiao, K., Lyu, M., Huang, Q., Zhang, T., & Tang, B. Z. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102106 · Cited by 34
Self-citationCline, B. L., Jiang, W., Lee, C., Cao, Z., Yang, X., Zhan, S., Chong, H., Zhang, T., Han, Z., Wu, X., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c01435 · Cited by 32
Self-citationCold Exposure Therapy Sensitizes Nanodrug-Mediated Radioimmunotherapy of Breast Cancer
Qiao, K., You, P., Zhang, S., Shi, G., Yang, J., Zhang, Z., Wang, K., Chen, X. S., & Ning, S. (2024) · ACS Nano · doi:10.1021/acsnano.4c09021 · Cited by 32
Self-citationRadiotherapy assisted with biomaterials to trigger antitumor immunity
Yu, X., Ma, H., Xu, G., & Liu, Z. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.02.049 · Cited by 31
Wu, X., Zhang, J., Deng, Z., Sun, X., Zhang, Y., Zhang, C., Wang, J., Yu, X., & Yang, G. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123000 · Cited by 30
Yu, H., Guo, H., Zu, H., Ding, H., Lin, S., Wang, Y., Zhang, L. W., & Wang, Y. (2022) · Aggregate · doi:10.1002/agt2.194 · Cited by 30
Wang, X., Yang, Y., Wang, P., Li, Q., Gao, W., Sun, Y., Tian, G., Zhang, G., & Xiao, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.049 · Cited by 26
Self-citationLiu, Y., Suo, X., Peng, H., Yan, W., Li, H., Yang, X., Li, Z., Zhang, J., & Liu, D. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900160 · Cited by 25
Dey, A., Jeon, J., Yoon, B., Li, Y., & Park, J. H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.015 · Cited by 24
Chen, Z., Hu, F., Xiang, J., Zhou, X., Wu, B., Fan, B., Tang, H., Liu, B., & Chen, L. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c09833 · Cited by 22
Bionic aggregation-induced emission photosensitizer for enhanced cancer immunotherapy
Chen, Z., Liu, Z., Zhou, Y., Rao, K., Lin, J., Zhu, D., Ning, S., & Wang, H. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101217 · Cited by 21
Self-citationZaluzec, E. K., Kenyon, E., Volk, M., Hayat, H., Powell, K. L., Loomis, A., Chakravarty, S., Hix, J. M. L., Schipper, J., Chang, C., et al. (2024) · npj Imaging · doi:10.1038/s44303-024-00007-5 · Cited by 11
Li, M., Yu, Q., Anayyat, U., Yang, H., Wei, Y., & Wang, X. (2024) · GeroScience · doi:10.1007/s11357-024-01223-y · Cited by 10
KUBO, M., Satoh, T., Tabata, K., Tsumura, H., Iwamura, M., Baba, S., Thompson, T. C., & Obata, F. (2015) · Molecular and Clinical Oncology · doi:10.3892/mco.2015.519 · Cited by 9
Mertk signaling and immune regulation in T cells
Varsanyi, C., & Birge, R. B. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae253 · Cited by 7
Bořilová, S., Grell, P., Selingerová, I., Gescheidtová, L., Mlnaříková, M., Bílek, O., Lakomý, R., Poprach, A., Podhorec, J., Kišš, I., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-13351-x · Cited by 6
Biomedical applications of the engineered AIEgen-lipid nanostructure in vitro and in vivo
Suo, M., Zhang, T., & Liang, X. (2024) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ad9aeb · Cited by 4
Self-citationHe, C., Zhou, J., Ge, N., Zhang, X., Wang, X., & Yang, Y. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-1052 · Cited by 3
Self-citation
Cited by
Suo, M., Yang, D., Yang, M., Wang, J., Zhang, D., Zhu, D., Xu, Q., & Song, Y. (2025) · Advanced Science · doi:10.1002/advs.202518037 · Cited by 34
Self-citationXu, S., Huang, B., Lin, H., Li, J., Lu, Z., Zhang, Q., Li, J., Yang, S., Lan, S., Yang, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202516783 · Cited by 33
Wang, W., Liu, Y., Xu, J., Deng, Y., Chen, W., Lin, Y., Tang, B. Z., & Zhang, M. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217553 · Cited by 21
Self-citationThe Fast‐Growing Field of Cancer Immunotherapy Based on Aggregation‐Induced Emission
Lin, Z., He, T., Kang, M., Xie, W., Wang, D., & Tang, B. Z. (2025) · Aggregate · doi:10.1002/agt2.70189 · Cited by 17
“Upon internalization by 4T1 cells, THN generates ROS under X-ray irradiation to trigger ICD, polarizes M2-type TAM to M1-type TAM, and creates an immune-activated TME in animal model [152].”
Self-citationWang, J., Shu, Z., Chen, J., Bei, J., Wu, Y.-C., Chen, T., Wang, Y., Du, Y., & Yao, Y. S. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05397 · Cited by 9
Metadata
- Authors
- Xu, Q., Zhang, M., Huang, Q., Gao, S., Chu, S., Li, Q., Chen, W., Zhang, X., Zhang, T., Tang, B. Z., & Ning, S.
- Affiliations
- Harbin Medical University (CN)
- Liuzhou General Hospital (CN)
- Zhengzhou University (CN)
- Guangxi Medical University (CN)
- Guangzhou Medical University Cancer Hospital (CN)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Xu, Qingyong
- Zhang, Tianfu
- Tang, Ben Zhong
- Ning, Shipeng
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2025-06-19
- Volume
- 37
- Issue
- 35
- Pages
- e2502898-e2502898
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- PMC
- PMC12411993
- OpenAlex
- W4411434745
- Cited by
- 69
- References
- 67
- Citations by year
- 2026: 58 · 2025: 11
- FWCI
- 16.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Advanced Materials (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- National Natural Science Foundation of China (82303797, 82473348, 52303224)
- Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515010855)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
- Keywords
- aggregation-induced emission, reactive oxygen species generation, ferriprotoporphyrin IX, hemin, NOX4, hydrogen peroxide, hydroxyl radicals, chemodynamic therapy, radioimmunotherapy, immunogenic cancer cell death, M2 macrophage polarization, tumor recurrence, memory T cells, antitumor immunity
- MeSH terms
- Animals, Glutathione, Hemin, Humans, Hydrogen Peroxide, Neoplasms, Radiation-Sensitizing Agents, X-Rays, Reactive Oxygen Species, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.